thisdrug what a medicine's name tells you

WHO naming stem · infix · 44 listed names

-ki(n)-

target: interleukin

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -ki(n)- as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -ki(n)-. It has 2 spellings or places: kin inside the name, with letters before and after it (…kin…); ki inside the name, with letters before and after it (…ki…).

Of the 44 names WHO lists under it, 6 carry kin inside the name, with letters before and after it, 38 carry ki inside the name, with letters before and after it.

All 44 names WHO lists under -ki(n)-

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. abrezekimab
  2. avizakimab
  3. bermekimab
  4. bimekizumab
  5. briakinumab
  6. camoteskimab
  7. canakinumab
  8. cendakimab
  9. cergutuzumab amunaleukin
  10. clazakizumab
  11. depemokimab
  12. ebdarokimab
  13. eblasakimab
  14. enokizumab
  15. etokimab
  16. fezakinumab
  17. gevokizumab
  18. gumokimab
  19. itepekimab
  20. ixekizumab
  21. lebrikizumab
  22. lusvertikimab
  23. lutikizumab
  24. manfidokimab
  25. mirikizumab
  26. netakimab
  27. olokizumab
  28. ordesekimab
  29. perakizumab
  30. pivekimab
  31. pivekimab sunirine
  32. risankizumab
  33. romilkimab
  34. secukinumab
  35. sonelokimab
  36. tildrakizumab
  37. torudokimab
  38. tozorakimab
  39. tralokinumab
  40. tucotuzumab celmoleukin
  41. ustekinumab
  42. vunakizumab
  43. xeligekimab
  44. ziltivekimab

Decode another name

Decoded

briakinumab

Listed INNCarries 2 WHO stems, most specific first: -ki(n)- …

  • -ki(n)-inside the nameWHO lists it hereWHO definition: target: interleukin
  • -mabend of the nameWHO lists it hereWHO definition: monoclonal antibodies (previous naming scheme)

“briakinumab” is an INN that WHO lists under -ki(n)-, -mab in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -ki(n)- (Part II B) and the 44 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.